Literature DB >> 22031941

Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Liisi Võsa1, Aleksander Sudakov, Maido Remm, Mart Ustav, Reet Kurg.   

Abstract

Papillomavirus E2 protein is required for the replication and maintenance of viral genomes and transcriptional regulation of viral genes. E2 functions through sequence-specific binding to 12-bp DNA motifs-E2 binding sites (E2BS)-in the virus genome. Papillomaviruses are able to establish persistent infection in their host and have developed a long-term relationship with the host cell in order to guarantee the propagation of the virus. In this study, we have analyzed the occurrence and functionality of E2BSs in the human genome. Our computational analysis indicates that most E2BSs in the human genome are found in repetitive DNA regions and have G/C-rich spacer sequences. Using a chromatin immunoprecipitation approach, we show that human papillomavirus type 11 (HPV11) E2 interacts with a subset of cellular E2BSs located in active chromatin regions. Two E2 activities, sequence-specific DNA binding and interaction with cellular Brd4 protein, are important for E2 binding to consensus sites. E2 binding to cellular E2BSs has a moderate or no effect on cellular transcription. We suggest that the preference of HPV E2 proteins for E2BSs with A/T-rich spacers, which are present in the viral genomes and underrepresented in the human genome, ensures E2 binding to specific binding sites in the virus genome and may help to prevent extensive and possibly detrimental changes in cellular transcription in response to the viral protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031941      PMCID: PMC3255907          DOI: 10.1128/JVI.05606-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Interaction of the papillomavirus E2 protein with mitotic chromosomes.

Authors:  N Bastien; A A McBride
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.

Authors:  Baki Akgül; Ramón García-Escudero; Christine Ekechi; Gertrud Steger; Harshad Navsaria; Herbert Pfister; Alan Storey
Journal:  Med Microbiol Immunol       Date:  2011-01-28       Impact factor: 3.402

3.  The structural basis of DNA target discrimination by papillomavirus E2 proteins.

Authors:  S S Kim; J K Tam; A F Wang; R S Hegde
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

4.  Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter.

Authors:  Daeyoup Lee; Hak-Zoo Kim; Kwi Wan Jeong; Young Sam Shim; Izumi Horikawa; J Carl Barrett; Joonho Choe
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

5.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.

Authors:  Ming Jiang; Jo Milner
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

6.  The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells.

Authors:  Stacy M Horner; Daniel DiMaio
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability.

Authors:  A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2008-11-26       Impact factor: 5.157

8.  The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes.

Authors:  Monika Oldak; Hans Smola; Monique Aumailley; Francisco Rivero; Herbert Pfister; Sigrun Smola-Hess
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus.

Authors:  Ghislaine Dell; Kay W Wilkinson; Rebecca Tranter; Joanna Parish; R Leo Brady; Kevin Gaston
Journal:  J Mol Biol       Date:  2003-12-12       Impact factor: 5.469

10.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more
  15 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Cytotoxicity and DNA cleavage with core-shell nanocomposites functionalized by a KH domain DNA binding peptide.

Authors:  Remon Bazak; Jan Ressl; Sumita Raha; Caroline Doty; William Liu; Beau Wanzer; Seddik Abdel Salam; Samy Elwany; Tatjana Paunesku; Gayle E Woloschak
Journal:  Nanoscale       Date:  2013-12-07       Impact factor: 7.790

3.  Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Authors:  Elaine J Gauson; Mary M Donaldson; Edward S Dornan; Xu Wang; Molly Bristol; Jason M Bodily; Iain M Morgan
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 4.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

5.  Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.

Authors:  Elaine J Gauson; Xu Wang; Edward S Dornan; Pawel Herzyk; Molly Bristol; Iain M Morgan
Journal:  Virus Res       Date:  2015-09-10       Impact factor: 3.303

Review 6.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

7.  Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification.

Authors:  Tormi Reinson; Mart Toots; Meelis Kadaja; Regina Pipitch; Mihkel Allik; Ene Ustav; Mart Ustav
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

8.  Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions.

Authors:  Luciana Bueno Freitas; Zigui Chen; Elaine Freire Muqui; Neide Aparecida Tosato Boldrini; Angélica Espinosa Miranda; Liliana Cruz Spano; Robert D Burk
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Authors:  Elaine J Gauson; Brad Windle; Mary M Donaldson; Maria M Caffarel; Edward S Dornan; Nicholas Coleman; Pawel Herzyk; Scott C Henderson; Xu Wang; Iain M Morgan
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

10.  The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome Pathway.

Authors:  Kadri Õunap; Lilian Leetsi; Maarja Matsoo; Reet Kurg
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.